CHD2-related syndrome is caused by random mutations in the CHD2 gene that may not be directly inherited. Dual-parent whole-exome sequencing is required to detect. Children and their families endure a journey marked by what can be severe developmental epilepsies, autism, developmental delays and intellectual delay, with little public understanding and virtually no roadmap for care. CHD2 Canada wants to change this situation. We are on a mission to: - Advance Canadian and international research on CHD2 - Advocate for early genetic sequencing, newborn screening and personalized pathways to care. - Provide support, relief and connection for Canadian families as we navigate systems and access to near-future trials and therapies.
| Employees | 1 (0 on RocketReach) |
| Founded | 2025 |
| Industry | Health and Human Services |
Looking for a particular CHD2 Canada employee's phone or email?
CHD2 Canada Questions
CHD2 Canada is based in Ottawa, Ontario.
